Press Releases

Here is an up-to-date collection of any information given to the press. It’s a big collection, so try not to look at it all in one sitting.

Press Releases

 
Press Releases
Date Title and Summary View
Nov 21, 2005 NEW YORK, NY - November 21, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today the publication of abstracts on its lead product candidate, ZIO-101. The preclinical abstracts are published and available online in Blood, the official journal of the American Society of Hematology. The abstracts include: Abstract 5163:...
PDF
Nov 18, 2005 PHILADELPHIA, PA - November 18, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that preclinical data for ZIO-102, an organic arsenic derivative, was presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Philadelphia, PA. The abstract titled "Mechanisms of increased reactive oxy...
PDF
Nov 16, 2005 PHILADELPHIA, PA - November 16, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that ZIO-101, a novel organic arsenic, has demonstrated safety at doses approximately 25 times higher than the currently approved dose for arsenic trioxide, an inorganic arsenic, in an ongoing Phase I trial that has treated 11 patients to date at The...
PDF
Oct 31, 2005 NEW YORK, NY - October 31, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Monday, November 7, 2005 at 8:40 a.m. EST at The New York Palace Hotel in New York, NY. Dr. Lewis will provide an overview ...
PDF
Oct 27, 2005 NEW YORK, NY - October 27, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that Richard Bagley, President and Chief Operating Officer, will present at the MASS Opportunities Partnering Forum on Thursday, November 3, 2005 at 11:20 a.m. EST at the Hilton Boston Logan Airport in Boston, MA. Mr. Bagley will provide an overview of th...
PDF
Oct 19, 2005 NEW YORK, NY - October 19, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announ ced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Wednesday, October 26, 2005 a t 4:00 p.m. EST at The New York Palace Hotel in New York, NY. Dr. Lewis will pro vide an overview of th...
PDF
Oct 14, 2005 New York, NY - October 14, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the BIO Investor Forum on Thursday, October 20, 2005 at 11:40 a.m. PST (2:40 p.m. EST) at the Palace Hotel in San Francisco, CA. Dr. Lewis will provide an overview of the Company and an upd...
PDF
Sep 26, 2005 New York, NY - September 26, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today its ticker symbol has changed from "ESWB" to "ZIOP". The symbol change, which is effective as of the opening of business today, is a result of the Company's previously announced merger with ZIOPHARM, Inc. In connection with the merger, the combined comp...
PDF
Sep 15, 2005 New York, NY and Englewood, CO - September 15, 2005 - ZIOPHARM, Inc. (private) and EasyWeb, Inc. (OTC Bulletin Board: ESWB.OB) today announced that they have completed the previously announced merger of the two companies. The Company's common stock trades on the OTC Bulletin Board under the symbol "ESWB.OB" until a new ticker symbol has been ...
PDF
Jun 6, 2005 CHARLESTOWN, MA June 6, 2005 - ZIOPHARM, Inc. announced today that it had completed its Series A Convertible Preferred Stock offering. Paramount BioCapital, Inc. served as the lead placement agent and gross proceeds were approximately $18.1 million. The net proceeds from the Offering will be used for research and development, licensing fees a...
PDF
Page: FirstPrevious ...
37
NextLast